Terms: = Bone cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Prognosis
11 results:
1. Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma.
Du M; Gu J; Liu C; Liu N; Yu Z; Zhou C; Heng W; Cao Z; Wei F; Zhu K; Wang Y; Zhang W; Xue X; Zhang Y; Qian J
J Exp Clin Cancer Res; 2022 Apr; 41(1):154. PubMed ID: 35459258
[TBL] [Abstract] [Full Text] [Related]
2. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
[TBL] [Abstract] [Full Text] [Related]
3. A new relative tumor sizing method in epi-metaphyseal osteosarcoma.
Kim SH; Shin KH; Park EH; Cho YJ; Park BK; Suh JS; Yang WI
BMC Cancer; 2015 Apr; 15():284. PubMed ID: 25885468
[TBL] [Abstract] [Full Text] [Related]
4. Useful markers for detecting minimal residual disease in cases of neuroblastoma.
Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
Biol Pharm Bull; 2008 Jun; 31(6):1071-4. PubMed ID: 18520032
[TBL] [Abstract] [Full Text] [Related]
5. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi anemia.
Gennery AR; Slatter MA; Bhattacharya A; Barge D; Haigh S; O'Driscoll M; Coleman R; Abinun M; Flood TJ; Cant AJ; Jeggo PA
Clin Immunol; 2004 Nov; 113(2):214-9. PubMed ID: 15451479
[TBL] [Abstract] [Full Text] [Related]
6. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.
Adachi Y; Reynolds PN; Yamamoto M; Wang M; Takayama K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2001 Nov; 61(21):7882-8. PubMed ID: 11691808
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic neuroblastoma with ganglioneuromatous differentiation and mandibular involvement.
Bhattacharyya I; Williamson A; Cohen DM; Bever JL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Nov; 88(5):586-92. PubMed ID: 10556754
[TBL] [Abstract] [Full Text] [Related]
8. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases.
Hachitanda Y; Hata J
Hum Pathol; 1996 Nov; 27(11):1135-8. PubMed ID: 8912820
[TBL] [Abstract] [Full Text] [Related]
9. Tumor size and prognosis in aggressively treated osteosarcoma.
Bieling P; Rehan N; Winkler P; Helmke K; Maas R; Fuchs N; Bielack S; Heise U; Jurgens H; Treuner J; Romanowski R; Exner U; Kotz R; Winkler K
J Clin Oncol; 1996 Mar; 14(3):848-58. PubMed ID: 8622033
[TBL] [Abstract] [Full Text] [Related]
10. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
[TBL] [Abstract] [Full Text] [Related]
11. [The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].
Rehan N; Bieling P; Winkler P; Helmke K; Maas R; Baldini N; Heise U; Fuchs N; Winkler K
Klin Padiatr; 1993; 205(4):200-9. PubMed ID: 8377444
[TBL] [Abstract] [Full Text] [Related]
